INVESTORS
We stand on the shoulders of giants
We simply couldn’t do it without the financial and intellectual support of our investors and advisors.
Pre-seed + seed funding
Abzu has raised a total of €8.1M, and last closed a seed round in April 2021 for €4.9M.
Abzu advisory board
We’re backed by senior experts in AI and life science.

Head of the Danish pioneer Centre for AI, professor of Computer Science at the University of Copenhagen, former Associate Dean at Cornell Tech, and visiting faculty member at Google.

Former Managing Partner at Lundbeckfonden Ventures. Board member of Dysis Medical, Cydan Development, Lexeo, Psioxus, and scPharmaceuticals. Co-founder and previous CEO of 7TM Pharma A/S.

Anders Gersel Pedersen
Former Executive Vice President of Research + Development at Lundbeck. Deputy Chair of Bavarian Nordic and board member of Genmab, Hansa Medical, and Avillion.

President and CEO at Scandion Oncology. Former positions include President of Genevant Sciences, Global Head of RNA Therapeutics at Roche Innovation Center Copenhagen.
Awards + nominations
We are thrilled and honored to be recognized for our innovative technology and unique organization.






Abzu's origin story
In 2018, seven founders from Denmark, Italy, and Spain combined their knowledge in high-performance computing, AI, and systems-level software engineering to bring a bold idea to life.
Our technology: The QLattice®
We created a new class of artificial intelligence to accelerate scientific research: An explainable AI that carefully reveals the simplest explanation from vast amounts of observational data.


Raising for Series A
The technical challenge of building the QLattice is solved. Now we are raising a round of funding to help accelerate the development of new custom-made tools built on the engine of the QLattice.
Contact Abzu
We’re just a bunch of nice nerds building something new and awesome. How can we help you?